Duke CTSA (Composite)
Duke CTSA (Composite)
批准号:
9263770
负责人:
Leigh E Boulware
金额:
$131.92万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-26 至 2018-10-31
关键词:
BiometryClinical ResearchClinical TrialsCommunitiesDevelopmentDisciplineDiseaseEducationElectronic Health RecordEnsureEnvironmentEthicsFosteringFundingGoalsHealth SciencesHealth ServicesHealth systemHome environmentHumanInformation TechnologyInstructionLearningLinkMentorsOutcomePatient-Focused OutcomesPopulation ResearchProcessProductivityRecruitment ActivityRegistriesResearchResearch InfrastructureResearch PersonnelResourcesSafetySchoolsScienceSiteSystemTrainingTraining ProgramsTranslational ResearchTranslationsUpdateVisionbasebench to bedsidebiobankcostcost effectivenessimplementation scienceimproved outcomeinnovationmedical specialtiesmulti-site trialnew technologynext generationsystems researchtool
中文摘要
为了实现CTSA联盟的新NCATS愿景,并加速科学发现,
为了患者的健康,学术健康和科学系统必须投资,转型和创新,
优化其独特优势。我们的愿景,与NCATS的一致,是创造一个研究环境,
在杜克大学,通过将发现与发现联系起来,
科学成为创新引擎,有效加速新技术的发展; 2)整合
临床试验,登记,和电子健康记录在学习健康系统,研究和
实践是一个连续体。我们的研究环境将由科学价值和社会需求驱动,
对疾病或专业学科“不可知论”,与我们最新的研究机构框架保持一致
监督和质量,并不断评估学术生产力,效率和成本。实现
为了实现这些目标,我们将通过提供以下服务为临床和转化研究创建一个综合之家:
基础设施和资源,为整个研究领域的研究人员和学员提供服务。我们将提供
基于我们研究人员的共同需求的资源,包括教育,生物统计,生物库,
监管专门知识、道德操守、试点资金和招聘援助。我们还将定制我们的产品,
跨研究社区的专业需求,包括早期翻译、概念验证、基于站点的
研究和基于人口的研究,包括多地点试验,结果,卫生服务,
实施科学和社区参与研究。整合这些资源将需要一个新的
工具,所有学员和研究人员的门户网站,MyResearchHome(gDuke,及其人类对应物,
MyResearchTeam(gDuke.这些工具将为所有临床和翻译提供单一入口点
研究在杜克,无论他们的部门或学校。因此,我们将加强我们的综合家园,
结合先进的信息技术和指导的临床和转化研究
和导航;为我们所有的翻译研究提供公共和专业资源
社区,并在我们的教育和培训计划中培养下一代研究人员。
相关性(参见说明):
CTSA将促进转化研究过程,确保开发新发现,
更快地进行评估,并以高质量、高效率、高安全性和高成本完成临床研究-
有效性
英文摘要
To fulfill the new NCATS vision for the CTSA Consortium and accelerate scientific discoveries into improved
outcomes for patients, academic health and science systems must invest, transform, and innovate to
optimize their unique strengths. Our vision, aligned with that of NCATS, is to create a research environment
at Duke that stimulates the translation of scientific discovery from bench to bedside by 1) linking discovery
science to a creative engine that efficiently accelerates development of new technologies; and 2) integrating
clinical trials, registries, and electronic health records in a learning health system where research and
practice form a continuum. Our research environment will be driven by scientific merit and societal need,
"agnostic" to disease or specialty discipline, aligned with our updated institutional framework for research
oversight and quality, and continually evaluated for academic productivity, efficiency, and cost. To achieve
these goals, we will create an Integrated Home for clinical and translational research by providing
infrastructure and resources to serve investigators and trainees across the research spectrum. We will offer
resources based upon common needs among our researchers, including education, biostatistics, biobanking,
regulatory expertise, ethics, pilot funding and recruitment assistance. We will also tailor our offerings to
specialized needs across research communities that include early translation, proof of concept, site-based
research and population' based research, which includes multi-site trials, outcomes, health services,
implementation science and community engaged research. Integrating these resources will require a new
tool, a portal for all trainees and investigators, MyResearchHome(gDuke, and its human counterpart,
MyResearchTeam(gDuke. These tools will provide a single point of entry for all clinical and translational
research at Duke, regardless of their department or school. Thus, we will enhance our Integrated Home for
clinical and translational research with a combination of sophisticated information technology and mentoring
and navigation; provide access to common and specialized resources for all of our translational research
communities and train the next generation of researchers in our educational and training programs.
RELEVANCE (See instructions):
The CTSA will foster the translational research process, ensuring that new discoveries are developed and
evaluated more quickly and that clinical research is done with high quality, efficiency, safety and cost-
effectiveness.
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1017/s1047951114002522
发表时间:
2015-10
期刊:
Cardiology in the young
影响因子:
1
作者:
[Wisotzkey BL, Hornik CP, Green AS, Barker PC]
通讯作者:
Barker PC
A Plan for Academic Biobank Solvency-Leveraging Resources and Applying Business Processes to Improve Sustainability.
学术生物库偿付能力计划——利用资源并应用业务流程来提高可持续性。
DOI:
10.1111/cts.12287
发表时间:
2015
期刊:
Clinical and translational science
影响因子:
--
作者:
[Uzarski,Diane, Burke,James, Turner,Barbara, Vroom,James, Short,Nancy]
通讯作者:
Short,Nancy
DOI:
10.1111/ner.12689
发表时间:
2018-01
期刊:
Neuromodulation : journal of the International Neuromodulation Society
影响因子:
--
作者:
[Elsamadicy AA, Sergesketter A, Ren X, Mohammed Qasim Hussaini S, Laarakker A, Rahimpour S, Ejikeme T, Yang S, Pagadala P, Parente B, Xie J, Lad SP]
通讯作者:
Lad SP
Congenital Heart Disease in Premature Infants 25-32 Weeks' Gestational Age.
早产婴儿的先天性心脏病25-32周的胎龄。
DOI:
10.1016/j.jpeds.2016.10.033
发表时间:
2017-02
期刊:
The Journal of pediatrics
影响因子:
--
作者:
[Chu PY, Li JS, Kosinski AS, Hornik CP, Hill KD]
通讯作者:
Hill KD
DOI:
10.1002/ccd.27793
发表时间:
2018-12-01
期刊:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
影响因子:
--
作者:
[Hill KD, Mann SD, Carboni MP, Doyle TP, Idriss SF, Janssen DF, Nicholson GT, Sathanandam S, Fleming GA]
通讯作者:
Fleming GA
共 34 条
Lancet Commission on Hearing Loss-CTSA Administrative Supplement
-
批准号:10190037
-
项目类别:
-
资助金额:$58.15万
-
财政年份:2020
-
负责人:Leigh E Boulware
-
依托单位:
Health system outreach to eliminate disparities in living kidney transplants
-
批准号:10167095
-
项目类别:
-
资助金额:$397.45万
-
财政年份:2020
-
负责人:Leigh E Boulware
-
依托单位:
Stress, Coping and Asthma in Black Adults
-
批准号:10295379
-
项目类别:
-
资助金额:$4.56万
-
财政年份:2018
-
负责人:Leigh E Boulware
-
依托单位:
Support for QA/QC for Prior Approval Process
-
批准号:10158677
-
项目类别:
-
资助金额:$18.02万
-
财政年份:2018
-
负责人:Leigh E Boulware
-
依托单位:
Duke CTSA
-
批准号:10159995
-
项目类别:
-
资助金额:$1005.93万
-
财政年份:2018
-
负责人:Leigh E Boulware
-
依托单位:
Breaking down care process and patient-level barriers to arteriovenous access creation prior to hemodialysis initiation
-
批准号:9763553
-
项目类别:
-
资助金额:$20.21万
-
财政年份:2018
-
负责人:Leigh E Boulware
-
依托单位:
Duke CTSA (Composite)
-
批准号:9515228
-
项目类别:
-
资助金额:$3.98万
-
财政年份:2013
-
负责人:Leigh E Boulware
-
依托单位:
Duke CTSA (Composite)
-
批准号:8867319
-
项目类别:
-
资助金额:$860.75万
-
财政年份:2013
-
负责人:Leigh E Boulware
-
依托单位:
Duke CTSA (Composite)
-
批准号:9266211
-
项目类别:
-
资助金额:$10.49万
-
财政年份:2013
-
负责人:Leigh E Boulware
-
依托单位:
Duke CTSA (Composite)
-
批准号:8899918
-
项目类别:
-
资助金额:$44.93万
-
财政年份:2013
-
负责人:Leigh E Boulware
-
依托单位:
Duke CTSA (Composite)
-
批准号:8743359
-
项目类别:
-
资助金额:$35.53万
-
财政年份:2013
-
负责人:Leigh E Boulware
-
依托单位:
Duke CTSA (Composite)
-
批准号:8743358
-
项目类别:
-
资助金额:$87.95万
-
财政年份:2013
-
负责人:Leigh E Boulware
-
依托单位:
Duke CTSA (Composite)
-
批准号:8743360
-
项目类别:
-
资助金额:$907.74万
-
财政年份:2013
-
负责人:Leigh E Boulware
-
依托单位:
Duke CTSA (Composite)
-
批准号:8913325
-
项目类别:
-
资助金额:$7.17万
-
财政年份:2013
-
负责人:Leigh E Boulware
-
依托单位:
Duke CTSA (Composite)
-
批准号:9058625
-
项目类别:
-
资助金额:$860.75万
-
财政年份:2013
-
负责人:Leigh E Boulware
-
依托单位:
Potential Barriers and Facilitators to Living Donor Kidney Transplantation Among Black Americans
-
批准号:9258697
-
项目类别:
-
资助金额:$8.9万
-
财政年份:2012
-
负责人:Leigh E Boulware
-
依托单位:
Transplant Social Worker Support for Live Kidney Donation in African Americans
-
批准号:8707449
-
项目类别:
-
资助金额:$27.48万
-
财政年份:2012
-
负责人:Leigh E Boulware
-
依托单位:
Transplant Social Worker Support for Live Kidney Donation in African Americans
-
批准号:8502992
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2012
-
负责人:Leigh E Boulware
-
依托单位:
Transplant Social Worker Support for Live Kidney Donation in African Americans
-
批准号:8547806
-
项目类别:
-
资助金额:$0.84万
-
财政年份:2012
-
负责人:Leigh E Boulware
-
依托单位:
Transplant Social Worker Support for Live Kidney Donation in African Americans
-
批准号:8823072
-
项目类别:
-
资助金额:$26.51万
-
财政年份:2012
-
负责人:Leigh E Boulware
-
依托单位:
海外基金